CRIVELLARO, CINZIA
 Distribuzione geografica
Continente #
NA - Nord America 11.184
AS - Asia 5.891
EU - Europa 4.984
SA - Sud America 915
Continente sconosciuto - Info sul continente non disponibili 566
AF - Africa 143
OC - Oceania 35
Totale 23.718
Nazione #
US - Stati Uniti d'America 10.542
SG - Singapore 1.891
IT - Italia 1.621
CN - Cina 1.236
VN - Vietnam 1.209
BR - Brasile 713
DE - Germania 640
HK - Hong Kong 626
RU - Federazione Russa 614
CA - Canada 508
SE - Svezia 457
IE - Irlanda 320
GB - Regno Unito 272
FR - Francia 222
UA - Ucraina 200
IN - India 176
BD - Bangladesh 148
AT - Austria 116
FI - Finlandia 95
TR - Turchia 90
ES - Italia 87
KR - Corea 74
IQ - Iraq 73
AR - Argentina 63
DK - Danimarca 63
NL - Olanda 60
PL - Polonia 59
MX - Messico 57
ID - Indonesia 53
JP - Giappone 49
EC - Ecuador 43
ZA - Sudafrica 40
PK - Pakistan 37
AU - Australia 33
CH - Svizzera 32
PH - Filippine 30
CO - Colombia 29
BE - Belgio 28
SA - Arabia Saudita 24
KE - Kenya 23
UZ - Uzbekistan 23
VE - Venezuela 23
CZ - Repubblica Ceca 22
JM - Giamaica 21
MA - Marocco 19
JO - Giordania 16
MY - Malesia 16
PY - Paraguay 16
CL - Cile 13
CR - Costa Rica 12
AE - Emirati Arabi Uniti 11
BG - Bulgaria 11
EG - Egitto 11
LT - Lituania 11
PS - Palestinian Territory 11
TH - Thailandia 11
HN - Honduras 10
OM - Oman 10
PT - Portogallo 10
TN - Tunisia 10
AZ - Azerbaigian 9
IR - Iran 8
RO - Romania 8
TW - Taiwan 8
DZ - Algeria 7
EU - Europa 7
UY - Uruguay 7
AL - Albania 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
GR - Grecia 6
IL - Israele 6
NI - Nicaragua 6
EE - Estonia 5
HU - Ungheria 5
KZ - Kazakistan 5
LB - Libano 5
SC - Seychelles 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BB - Barbados 4
BO - Bolivia 4
GE - Georgia 4
LK - Sri Lanka 4
NG - Nigeria 4
NP - Nepal 4
PA - Panama 4
PE - Perù 4
PR - Porto Rico 4
SN - Senegal 4
GT - Guatemala 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
MO - Macao, regione amministrativa speciale della Cina 3
SO - Somalia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
CY - Cipro 2
GA - Gabon 2
Totale 23.127
Città #
Ann Arbor 1.578
Singapore 1.177
Ashburn 1.082
San Jose 724
Hong Kong 586
Milan 497
Chandler 466
Fairfield 455
Woodbridge 415
Ho Chi Minh City 395
Frankfurt am Main 393
Wilmington 360
Houston 356
Toronto 327
Dublin 306
Hanoi 271
New York 246
Dearborn 234
Los Angeles 234
Santa Clara 219
Dallas 200
Seattle 200
Council Bluffs 188
Beijing 179
Jacksonville 173
Cambridge 162
Chicago 136
The Dalles 126
Hefei 117
Boardman 116
Princeton 113
Shanghai 110
Lissone 101
Vienna 98
Nanjing 87
Rome 82
Lauterbourg 78
São Paulo 73
Buffalo 69
Columbus 65
Seoul 64
Munich 62
Da Nang 55
Altamura 51
Moscow 50
Lawrence 49
Orem 49
Montreal 46
London 44
Guangzhou 40
Fremont 38
Monza 37
Phoenix 36
Brooklyn 35
Chennai 35
Haiphong 35
Warsaw 35
Helsinki 34
San Diego 34
Tokyo 34
Atlanta 33
Ottawa 32
Denver 31
Jakarta 31
Nanchang 29
Amsterdam 28
Johannesburg 28
Lachine 27
Nuremberg 27
Falls Church 26
Biên Hòa 24
Boston 24
Stockholm 24
Brussels 23
Jinan 23
Shenyang 23
Turku 23
Washington 23
Ha Long 22
Paris 22
Poplar 22
Baghdad 21
Bologna 21
Dhaka 21
Dong Ket 21
Nairobi 21
Naples 21
Florence 20
Manchester 20
Newark 20
Rio de Janeiro 20
Mumbai 19
Tashkent 19
Andover 18
Hangzhou 18
Kunming 18
Salt Lake City 18
Tianjin 18
Brno 17
Figino 17
Totale 14.570
Nome #
Cognitive profile and metabolic brain imaging in late-onset PCA compared with early-onset PCA and senile amnesic AD 587
Treatment response assessment in [18F]FDG-PET/CT oncology scans: Impact of count statistics variation and reconstruction protocol 557
A Metabolic Imaging Study of Lexical and Phonological Naming Errors in Alzheimer Disease 503
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 502
18F-FDG PET/CT in a Case of Metastatic Breast Cancer to the Vulva 477
Role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in malignant ovarian germ cell tumors: a single-center experience with long term follow-up 474
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 470
Cardiotoxicity in breast cancer patients: the role of gated myocardial perfusion SPECT 448
18F-FDG-PET/CT guiding to diagnosis of neurosarcoidosis 447
Added diagnostic value of respiratory-gated 4D 18F–FDG PET/CT in the detection of liver lesions: a multicenter study 430
Cognitive reserve maps the core loci of neurodegeneration in corticobasal degeneration 420
Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping 412
18F-FDG PET/CT in preoperative staging of vulvar cancer patients: Is it really effective? 395
Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer 99mTc and/or Blue Dye 392
Quality of Care for Cervical and Endometrial Cancer Patients: The Impact of Different Techniques of Sentinel Lymph Node Mapping on Patient Satisfaction 390
Sentinel-node mapping in endometrial cancer patients: comparing SPECT/CT, gamma-probe and dye 388
Neurocognitive heterogeneity of Posterior Cortical Atrophy 387
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 386
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 374
Respiratory motion management in PET/CT: applications and clinical usefulness 372
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study 370
Sentinel node biopsy in endometrial cancer: an update 368
Motion management in PET/CT: Technological solutions 366
Mapping category fluency to the ventral and dorsal language streams in PCA and semantic and logopenic PPA 363
Predictive value of 18F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study 361
Metabolic subtypes of Posterior Cortical Atrophy: a data-driven approach controlling for pathophysiology-related hypometabolism 360
From Conventional Radiotracer Tc-99m with Blue Dye to Indocyanine Green Fluorescence: A Comparison of Methods Towards Optimization of Sentinel Lymph Node Mapping in Early Stage Cervical Cancer for a Laparoscopic Approach 359
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT 357
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? 348
An optimized protocol for correlation of PET-FDG and pCASL data in mild cognitive impairment (MCI) patients 345
Clinical applicability of pCASL as a substitute for FDG-PET in the etiological diagnosis of MCI and SCD: CAPE study protocol 345
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 341
Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer 336
Validity of cingulate–precuneus–temporo-parietal hypometabolism for single-subject diagnosis of biomarker-proven atypical variants of Alzheimer’s Disease 330
The heterogeneity of lung perfusion patterns in SPECT/CT during COVID-19: not only embolism 324
Anatomical correlates of reading in the elderly brain: an FDG-PET analysis of the reading performance in Alzheimer's Disease 320
Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study 315
Metabolic parameters as biomarkers of response to immunotherapy and prognosis in non-small cell lung cancer (Nsclc): A real world experience 308
Clinical and neuroimaging characterization of the first frontotemporal dementia family carrying the MAPT p.K298E mutation 304
Left and right corticobasal syndrome: comparison of cognitive profiles between metabolic imaging - matched groups 302
Clinical and metabolic imaging features of late-onset and early-onset Posterior Cortical Atrophy 298
Validation of brain 18FDG-PET and pCASL joint analysis tool: a ROI-based approach 295
Depressive Pseudodementia with Reversible AD-like Brain Hypometabolism: A Case Report and a Review of the Literature 294
Cognitive profile of right and left Corticobasal Syndrome 289
[ 11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: Comparison with bone scintigraphy 286
11C-choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients 282
Clinical Application of a High Sensitivity BGO PET/CT Scanner: Effects of Acquisition Protocols and Reconstruction Parameters on Lesions Quantification 279
Unusual presentation of sarcoid-like reaction on bone marrow level associated with mediastinal lymphadenopathy on 18F-FDG-PET/CT resembling an early recurrence of Hodgkin's Lymphoma 276
Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm) 276
Contained rupture of common iliac artery aneurysm in a contrast-enhanced PET/CT study 272
A ROI-based quantitative pipeline for 18F-FDG PET metabolism and pCASL perfusion joint analysis: Validation of the 18F-FDG PET line 271
Role of PET/CT in the clinical management of locally advanced pancreatic cancer 270
Intrathoracic splenosis: Evaluation by 99mTc-labelled heat-denatured erythrocyte SPECT/CT 267
Real-Time Fluorescent Sentinel Lymph Node Mapping with Indocyanine Green in Women with Previous Conization Undergoing Laparoscopic Surgery for Early Invasive Cervical Cancer: Comparison with Radiotracer ± Blue Dye 267
Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer 260
Comparative analysis of iterative reconstruction algorithms with resolution recovery for cardiac SPECT studies. A multi-center phantom study 255
Focal bone lesions in hiv-positive patient treated with tenofovir 251
Learning From Mistakes: Cognitive and Metabolic Correlates of Errors on Picture Naming in the Alzheimer's Disease Spectrum 250
PET/CT and contrast enhanced CT in single vs. two separate sessions: a cost analysis study 248
Assessment of nodal status by 18F-FDG PET/CT in early stage ovarian cancer 244
PET-CT for treatment planning in prostate cancer 243
Molecular imaging in prostate cancer: [11C]choline PET/CT 221
A ROI-based quantitative pipeline for 18F-FDG PET metabolism and pCASL perfusion joint analysis: validation on 18F-FDG PET data 220
A cognitive marker for Alzheimer disease pathology in primary progressive aphasia? A validation study in the clinical setting 207
Clinical evidence on PET/CT for radiation therapy planning in prostate cancer 207
Comment on 'Pre-operative nomogram for the identification of lymph node metastasis in early cervical cancer' 205
Reduced phonemic fluency in progressive supranuclear palsy is due to dysfunction of dominant BA6 204
Performance of a SPECT collimator-detector response reconstruction algorithm: phantom studies and validation in inflammation clinical studies 197
Respiratory Gating and the performance of PET/CT in pulmonary lesions 187
Cervical injection for sentinel lymph nodes detection in endometrial cancers is controversial: response to comments 185
PET-Guided target delineation in a patient with lung cancer. 162
Next-generation radiomic sequencing in non-small cell lung cancer: an alternative model to predict mutations from [18F]FDG PET/CT 147
Identification of Alzheimer’s disease with 18F-FDG-PET and MRI pCASL in MCI and SCD subjects: the CAPE study 141
Guidelines for the screening and follow-up of infants born to anti-HCV positive mothers 129
Totale 23.718
Categoria #
all - tutte 69.827
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.827


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022750 0 0 0 116 64 71 56 54 53 92 99 145
2022/20231.834 182 531 152 219 112 281 13 108 97 45 53 41
2023/20241.307 53 54 74 77 140 294 235 70 67 38 21 184
2024/20253.179 155 334 169 136 207 181 236 112 273 582 307 487
2025/20269.263 1.401 623 686 1.002 1.040 433 1.309 351 633 696 566 523
2026/20271.402 248 349 764 41 0 0 0 0 0 0 0 0
Totale 23.718